PHASE-II STUDY OF ORAL VP-16-213 IN HEPATOCELLULAR-CARCINOMA

被引：27

作者：

CAVALLI, F

ROZENCWEIG, M

RENARD, J

GOLDHIRSCH, A

HANSEN, HH

机构：

[1] EUROPEAN ORG RES TREATMENT CANC,CTR DATA,INST JULES BORDET,BRUSSELS,BELGIUM

[2] INSELSPITAL,INST MED ONCOL,CH-3010 BERN,SWITZERLAND

[3] FINSEN INST,DK-2100 COPENHAGEN O,DENMARK

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1981年 / 17卷 / 10期

关键词：

D O I：

10.1016/0014-2964(81)90291-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1079 / 1082

页数：4

共 26 条

[1] BRUNNER KW, 1976, CANCER TREAT REP, V60, P1377
[2] CAVALLI F, 1977, SCHWEIZ MED WSCHR, V107, P1960
[3] CAVALLI F, 1978, CANCER TREAT REP, V62, P473
[4] COCHRANE AMG, 1977, CANCER, V40, P609, DOI 10.1002/1097-0142(197708)40:2<609::AID-CNCR2820400203>3.0.CO
[5] 2-L
[6] FALKSON G, 1978, CANCER, V42, P2149, DOI 10.1002/1097-0142(197811)42:5<2149::AID-CNCR2820420510>3.0.CO
[7] 2-5
[8] A PHASE-II STUDY OF NEOCARZINOSTATIN (NSC 157365) IN MALIGNANT HEPATOMA - AN EASTERN COOPERATIVE ONCOLOGY GROUP PILOT-STUDY
FALKSON, G
VONHOFF, D
KLAASSEN, D
DUPLESSIS, H
VANDERMERWE, CF
VANDERMERWE, AM
CARBONE, PP
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1980, 4 (01) : 33 - 36
[9] FOSTER JH, 1970, CANCER-AM CANCER SOC, V26, P493, DOI 10.1002/1097-0142(197009)26:3<493::AID-CNCR2820260302>3.0.CO
[10] 2-7